<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Phosphatidylcholine (diacyl) C32:0 increases Colorectal Cancer Stage IV — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Phosphatidylcholine (diacyl) C32:0</strong>
  <span class="pred">&mdash;increases&rarr;</span>
  <strong>Colorectal Cancer Stage IV</strong>
</div>
<div class="entity-id">UNKNOWN:phosphatidylcholine (diacyl) c32:0 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: DB Referenced (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 6.35<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (DB Referenced, 1 paper)<br>Score from 22 citations: <strong>6.35</strong><br><span style="color:#888">8&times; extends (+4.80) &middot; 6&times; supports (+3.00) &middot; 7&times; contradicts (-1.75) &middot; 1&times; applies (+0.30)</span><br>Neighbourhood: 9.19</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="DB Referenced"></span><span>DB Referenced</span><a href="https://doi.org/10.1002/ijc.32666">10.1002/ijc.32666</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 22 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:75px"></span><span>6</span><span class="cite-subtotal">&middot; +3.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">amino acids (plasma) — decreases → total fatigue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/99a0e9dbf318bdf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acylcarnitines — increases → total fatigue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/ac0e29ef3f10864d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites (138 metabolites panel) — correlates_with → reduced motivation (fatigue subdomain)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b61c440ca56b11e9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">amino acids (plasma) — decreases → fatigue severity</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d3f35386e474ff9b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Oleic acid — activates → Alpha-enolase (ENO1)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/54da3d35e5e4b09b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Allocholic acid — activates → Farnesoid X receptor-1 (FXR1)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/e889233c66e4f05a.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:88px"></span><span>7</span><span class="cite-subtotal">&middot; -1.75</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysophosphatidylcholines — decreases → total fatigue</span><span class="cite-claim-weight">-0.25</span><a href="../claim/dd2bcb86c633398a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">diacylphosphatidylcholines — decreases → total fatigue</span><span class="cite-claim-weight">-0.25</span><a href="../claim/558227bf016159c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acyl-alkylphosphatidylcholines — decreases → total fatigue</span><span class="cite-claim-weight">-0.25</span><a href="../claim/8fd3765ebc529aa9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelins — decreases → total fatigue</span><span class="cite-claim-weight">-0.25</span><a href="../claim/b402ffd8d62f9753.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites (138 metabolites panel) — is_biomarker_for → fatigue severity in colorectal cancer survivors</span><span class="cite-claim-weight">-0.25</span><a href="../claim/18a250f82c93c1b8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysophosphatidylcholines — decreases → fatigue severity</span><span class="cite-claim-weight">-0.25</span><a href="../claim/9bf841eec1d3e3d2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Allocholic acid — decreases → Colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/4d21474beac2eda1.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>8</span><span class="cite-subtotal">&middot; +4.80</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acylcarnitines — increases → fatigue severity</span><span class="cite-claim-weight">+0.60</span><a href="../claim/78c6dbc7679749e7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Oleic acid — increases → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/87bcc68b16bc437c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Oleic acid — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/4e9824be477ef6e0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Allocholic acid — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/320fd76a1b3b58d6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">17-plasma metabolite panel — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/b3471fc86dfe0573.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">17-plasma metabolite panel — predicts → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/fc08fef1586e3824.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Plasma metabolome — distinguishes → Colorectal adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/db6fd88273652deb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Fecal metabolome — distinguishes → Colorectal adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/7ada4059b7356b3a.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:12px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites — correlates_with → persistent fatigue in colorectal cancer survivors</span><span class="cite-claim-weight">+0.30</span><a href="../claim/61130e0fec38a3ad.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>20b11e9574370b5b</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:phosphatidylcholine (diacyl) c32:0">UNKNOWN:phosphatidylcholine (diacyl) c32:0</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
